Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.5140
+0.0338 (7.04%)
At close: Jul 25, 2025, 4:00 PM
0.5400
+0.0260 (5.06%)
After-hours: Jul 25, 2025, 7:59 PM EDT

Adial Pharmaceuticals Stock Forecast

ADIL's stock price has decreased by -56.81% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Adial Pharmaceuticals stock has a target of 8, which predicts a 1456.42% increase from the current stock price of 0.51.

Price Target: $8 (+1456.42%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$8.00$8.00$8.00$8.00
Change+1456.4%+1456.4%+1456.4%+1456.4%
* Price targets were last updated on Nov 14, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Adial Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Rodman & Renshaw
Rodman & Renshaw
Strong Buy
Initiates
$8
Strong BuyInitiates$8+1,456.42%Nov 14, 2024
Brookline Capital
Brookline Capital
Strong Buy
Reiterates
$150
Strong BuyReiterates$150+29,082.88%Jul 11, 2023
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 17, 2022
Brookline Capital
Brookline Capital
Strong Buy
Initiates
$300
Strong BuyInitiates$300+58,265.76%Oct 13, 2021
Litchfield Hills
Litchfield Hills
Strong Buy
Initiates
$125
Strong BuyInitiates$125+24,219.07%Jun 29, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 97.92M
Revenue Next Year
n/a
EPS This Year
-0.90
from -2.72
EPS Next Year
-1.02
from -0.90
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
Revenue
---47.94M97.92M
Revenue Growth
----104.26%---
EPS
-21.85-26.12-12.71-3.60-2.72-0.90-1.02-0.56
EPS Growth
--------
Forward PE
--------
No. Analysts
-----433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/an/a
Avgn/an/an/a
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-0.58-1.05-0.58
Avg-0.90-1.02-0.56
Low-1.20-0.98-0.54

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.